F 6 THR 12 -21.535 -20.438
F 7 CYS 25 -24.484 -24.543
F 8 PRO 3 -23.720 -21.337
F 9 ILE 19 -25.159 -24.451
F 10 PHE 28 -29.086 -28.961
F 11 TYR 16 -29.520 -27.965
F 12 ASP 19 -26.953 -26.038
F 13 VAL 34 -28.791 -29.390
F 14 PHE 30 -30.684 -30.605
F 15 PHE 11 -28.927 -26.865
F 16 ALA 23 -26.241 -25.868
F 17 VAL 29 -27.176 -27.386
F 18 ALA 24 -28.333 -27.835
F 19 ASN 14 -23.902 -22.763
F 20 GLY 16 -20.849 -20.292
F 21 ASN 9 -16.590 -15.717
F 22 GLU 9 -15.657 -14.891
F 23 LEU 0 -13.274 -11.747
F 24 LEU 14 -18.533 -18.012
F 25 LEU 26 -21.948 -22.414
F 26 ASP 3 -17.488 -15.822
F 27 LEU 11 -16.544 -15.906
F 28 SER 30 -21.468 -22.449
F 29 LEU 27 -20.252 -21.028
F 30 THR 6 -15.824 -14.694
F 31 LYS 23 -17.252 -17.913
F 32 VAL 36 -18.645 -20.641
F 33 ALA 7 -14.820 -13.921
F 34 ALA 33 -16.707 -18.581
F 35 THR 13 -12.276 -12.359
F 36 GLU 0 -10.836 -9.590
F 37 PRO 10 -10.977 -10.865
F 38 GLU 20 -15.822 -16.302
F 39 ARG 16 -15.594 -15.640
F 40 THR 12 -12.862 -12.763
F 41 ALA 23 -16.165 -16.951
F 42 MET 37 -22.401 -24.080
F 43 LYS 15 -17.194 -16.942
F 44 LYS 26 -16.676 -17.748
F 45 ILE 34 -23.363 -24.587
F 46 GLN 23 -21.773 -21.914
F 47 ASP 15 -18.233 -17.861
F 48 CYS 27 -20.351 -21.115
F 49 TYR 24 -21.665 -21.934
F 50 VAL 15 -17.565 -17.270
F 51 GLU 14 -14.258 -14.228
F 52 ASN 29 -15.919 -17.423
F 53 GLY 7 -16.355 -15.279
F 54 LEU 0 -17.943 -15.880
F 55 ILE 10 -17.652 -16.772
F 56 SER 25 -21.020 -21.477
F 57 ARG 18 -25.106 -24.288
F 58 VAL 5 -22.318 -20.327
F 59 LEU 25 -22.091 -22.426
F 60 ASP 34 -26.707 -27.546
F 61 GLY 17 -27.363 -26.171
F 62 LEU 18 -23.179 -22.584
F 63 VAL 38 -25.394 -26.843
F 64 MET 26 -27.845 -27.633
F 65 THR 10 -25.549 -23.761
F 66 THR 16 -20.307 -19.812
F 67 ILE 29 -24.048 -24.618
F 68 SER 14 -23.109 -22.061
F 69 SER 6 -18.715 -17.252
F 70 SER 22 -15.977 -16.670
F 71 LYS 2 -11.802 -10.674
F 72 ASP 18 -15.205 -15.526
F 73 CYS 19 -17.894 -18.021
F 94 ILE 23 -22.866 -22.882
F 95 CYS 17 -22.179 -21.583
F 96 PRO 2 -19.687 -17.653
F 97 ALA 19 -20.537 -20.361
F 98 VAL 29 -26.218 -26.538
F 99 LYS 16 -23.946 -23.032
F 100 ARG 17 -21.395 -20.890
F 101 ASP 30 -25.042 -25.612
F 102 VAL 31 -26.798 -27.282
F 103 ASP 11 -22.240 -20.948
F 104 LEU 23 -19.403 -19.817
F 105 PHE 34 -22.914 -24.189
F 106 LEU 27 -21.105 -21.783
F 107 THR 12 -13.091 -12.966
F 108 GLY 19 -13.129 -13.804
F 109 THR 3 -10.692 -9.808
F 110 PRO 13 -12.260 -12.345
F 111 ASP 0 -9.410 -8.328
F 112 GLU 11 -12.028 -11.910
F 113 TYR 27 -18.004 -19.039
F 114 VAL 19 -17.365 -17.553
F 115 GLU 5 -13.193 -12.251
F 116 GLN 24 -16.153 -17.055
F 117 VAL 32 -20.453 -21.781
F 118 ALA 11 -15.524 -15.004
F 119 GLN 14 -12.526 -12.696
F 120 TYR 30 -16.460 -18.017
F 121 LYS 24 -16.585 -17.438
F 122 ALA 4 -14.597 -13.378
F 123 LEU 12 -13.553 -13.375
F 124 PRO 0 -13.193 -11.676
F 125 VAL 11 -15.522 -15.002
F 126 VAL 21 -18.885 -19.128
F 127 LEU 13 -16.830 -16.389
F 128 GLU 7 -15.114 -14.181
F 129 ASN 24 -17.442 -18.196
F 130 ALA 30 -20.383 -21.489
F 131 ARG 12 -16.270 -15.779
F 132 ILE 21 -16.080 -16.646
F 133 LEU 39 -19.642 -21.868
F 134 LYS 27 -17.657 -18.731
F 135 ASN 9 -13.837 -13.281
F 136 CYS 23 -16.140 -16.928
F 137 VAL 36 -16.950 -19.141
F 138 ASP 18 -12.786 -13.386
F 139 ALA 11 -9.247 -9.449
F 140 LYS 23 -11.013 -12.391
F 141 MET 34 -11.827 -14.377
F 142 THR 6 -6.786 -6.695
F 143 GLU 0 -7.026 -6.218
F 144 GLU 5 -7.219 -6.964
F 145 ASP 19 -10.773 -11.719
F 146 LYS 18 -14.619 -15.008
F 147 GLU 4 -13.490 -12.399
F 148 ASN 22 -15.549 -16.291
F 149 ALA 31 -20.656 -21.846
F 150 LEU 18 -20.301 -20.036
F 151 SER 15 -17.066 -16.828
F 152 LEU 35 -20.764 -22.401
F 153 LEU 27 -24.814 -25.066
F 154 ASP 10 -18.980 -17.947
F 155 LYS 18 -19.296 -19.147
F 156 ILE 32 -22.807 -23.864
F 157 TYR 16 -21.893 -21.215
F 158 THR 6 -18.353 -16.933
F 159 SER 22 -19.347 -19.652
F 160 PRO 0 -16.054 -14.208
F 161 LEU 13 -19.347 -18.617
F 162 CYS 21 -22.894 -22.676
F 201  CA NA NA NA

Identified 0 B-Cell epitope residues out of 138 total residues